Projects
ENGAGE
project name: European Network for Genetic and Genomic Epidemiology
initiating country: The European Union
Framework Programme: FP7 programme area: Health contract type: CP-IP – Collaborative Integrated Project
contract/proposal/call number: 201413
status: active
start date: January 2008 duration: 60 months projected finish date: January 2013
Project Budget
total budget: € 16,566,640
Participants
Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level. Further details about the partners in this project can be found at the website listed below.
| name | organisation | state or country |
|---|---|---|
| Prof Nicholas Martin | QIMR | QLD, Australia |
| Helsingin yliopisto / Helsingfors universitet | Finland |
Further information
WWW: www.euengage.org
summary:
* To develop an enhanced supranational framework for research into genetic and genomic epidemiology that assembles the best researchers, the best sample and data sets in areas of primary focus (cardiovascular, metabolic, behavioural), the best ethical guidance and the best analytical and translational platforms;
* To accelerate discovery of disease-susceptibility genes through integrated analyses using multiple large-scale data sets and a range of experimental designs, thereby identifying novel aetiological pathways (with potential for pharmaceutical exploitation) and novel susceptibility variants and biomarkers (with potential as diagnostics as well as in guiding therapy development);
* To translate these findings into the clinical arena;
* To explore key methodological questions relevant to European research in this area (including for example, the consequences of ethnic and environmental heterogeneity for gene discovery efforts and the allelic architecture of common disease);
* To develop novel technological and statistical approaches for the study of human disease;
* To disseminate research outputs to both the scientific and non-specialist audience
* To contribute to international efforts in large population cohorts as exemplified by our very close contacts with the P3G effort (Public Population Projects in Genomics, www.p3g.org).
Source: consortium website
